Posted on 1/6/21
AmerisourceBergen Primed For A Bounce
SummaryAmerisourceBergen is a pharmaceutical distribution company that has seen solid earnings and revenue growth.The company does have a deal with the CDC to handle the distribution . . .
Posted on 1/5/21
Aro Biotherapeutics Closes $88 Million Series A
Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced the closing of an $88 million Series A financing. Northpond Ventures
Posted on 1/5/21
Quest Diagnostics: A COVID-19 Beneficiary
Summary Quest Diagnostics has effectively captured 24% of a $28Bn market, while earning the loyalty of 11Mn customers digitally by providing low cost, high quality services . . .
Posted on 1/5/21
ADMA Biologics: A Perfect Storm
Summary ADMA has been overly chastised by the market, and its business is performing very well.At its current trading level, ADMA is trading at just about . . .
Posted on 1/5/21
Johnson & Johnson Declares Fresh Dividend; Yield Is 2.6%
The beginning of the year is full of signature events. For many income investors, Johnson & Johnson's (NYSE:JNJ) first dividend declaration is one of them -- . . .
Posted on 1/4/21
Flowonix Medical and SWK Holdings Closes $33M Financing
Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty . . .
Posted on 1/4/21
Dun & Bradstreet - Increasingly Appealing
Summary Dun & Bradstreet has seen solid momentum since going public this summer.The company has seen solid topline sales growth in the first two quarterly earnings . . .
Posted on 1/4/21
Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.
The gap between the first and booster doses of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine has been widened substantially in the U.K. -- and Pfizer . . .
Posted on 1/4/21
Pfizer's Next Multibillion-Dollar COVID Vaccine Move
Pfizer (NYSE:PFE) made one of the smartest decisions in the company's long history earlier this year. It chose to partner with German biotech BioNTech (NASDAQ:BNTX) on . . .
Posted on 1/4/21
Why Did Johnson & Johnson Cut the Size of Its Coronavirus Vaccine Trial?
Johnson & Johnson(NYSE:JNJ) is trailing the leaders in the coronavirus vaccine race, but the healthcare giant is approaching the finish line, thanks to cutting the size . . .
Posted on 1/4/21
Should Investors Be Worried About Pfizer and BioNTech's Coronavirus Vaccine Rollout?
In this video from Motley Fool Live, recorded on Dec. 21, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss the . . .
Posted on 12/24/20
Is Johnson & Johnson Stock a Buy?
Although there's a lot to like about Johnson & Johnson (NYSE:JNJ), the company still has many qualities that might keep savvy investors on the sideline. A . . .
Posted on 12/24/20
Pfizer and BioNTech to Supply Feds With 100 Million Additional Doses of Coronavirus Vaccine
Still reeling from the coronavirus, the U.S. government has opted to double its take-up of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine. Both companies announced Wednesday . . .
Posted on 12/23/20
Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update
MONMOUTH JUNCTION, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg?for . . .
Posted on 12/23/20
Is Pfizer's COVID Vaccine Growth Story Already Over?
No matter how you look at it, Pfizer (NYSE:PFE) has had a remarkable year in 2020. The big drugmaker made a critical decision early on to . . .
Posted on 12/23/20
What Pfizer Wants You to Know About Its COVID Vaccine
Last week, some Americans began receiving their first dose of BNT162b2, the COVID-19 vaccine developed by Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX). Soon after the vaccine began shipping, Pfizer . . .
Posted on 12/22/20
Acorn Bioventures Invests in Cyclacel Pharmaceuticals
BERKELEY HEIGHTS, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company developing innovative medicines based on cancer cell . . .
Posted on 12/22/20
SCYNEXIS Closes of $85 Million Public Offering of Common Stock
JERSEY CITY, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously announced underwritten public offering of common . . .
Posted on 12/22/20
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology
CHATHAM, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced an agreement whereby Tonix has acquired . . .
Posted on 12/22/20
Pfizer and BioNTech's Coronavirus Vaccine Approved in Europe
Fresh off receiving its crucial emergency use authorization (EUA) in the U.S., Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine has received similar approval in Europe.Both companies . . .
Posted on 12/21/20
Provention Bio Announces Addition to NASDAQ Biotechnology Index
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it has been added to the NASDAQ Biotechnology . . .
Posted on 12/21/20
CapStone Holdings Invests $25 Million in Ilera Healthcare
CapStone Holdings, a business incubator and investment group, today announced a $25 million investment in TerrAscend's Ilera Healthcare Division, a vertically-integrated medical marijuana cultivator, processor, and . . .
Posted on 12/21/20
CapStone Holdings Invests $25 Million in Ilera Healthcare
CapStone Holdings, a business incubator and investment group, today announced a $25 million investment in TerrAscend's Ilera Healthcare Division, a vertically-integrated medical marijuana cultivator, processor, and . . .
Posted on 12/21/20
Does Pfizer's Vaccine Authorization Improve Moderna's Chances?
Pfizer(NYSE:PFE) received U.S. Emergency Use Authorization (EUA) for its COVID-19 vaccine on Dec. 11, 2020. This has raised hopes that Moderna(NASDAQ:MRNA) could soon win EUA for . . .
Posted on 12/21/20
Did U.K. and Canadian Authorizations of Pfizer's COVID Vaccine Pressure the U.S.?
On Dec. 12, 2020, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to BNT162b2, the COVID-19 vaccine developed by Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) . . .
Philadelphia
